Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Dietary butyrate delivery systems: NestleRecent Research Landscape

Uncontrolled volatility and rapid metabolism of short-chain fatty acids limit therapeutic bioavailability. Engineering specific butyrate delivery forms ensures targeted intestinal release and systemic absorption.

What technical problems is Nestle addressing in Dietary butyrate delivery systems?

Inadequate gastrointestinal butyrate delivery

(14)evidences

Butyrate is typically absorbed in the stomach and small intestine before reaching the colon. Preventing early uptake ensures therapeutic concentrations reach the distal gut.

Premature upper gastrointestinal absorption

(3)evidences

Free butyric acid possesses an extremely offensive odor and acrid taste that prevents consumer acceptance. Eliminating these sensory barriers allows for the incorporation of effective dosages into functional foods.